These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 12766717)
1. Levosimendan compared with dobutamine in low output patients. Nieminen MS Minerva Anestesiol; 2003 Apr; 69(4):258-63. PubMed ID: 12766717 [TBL] [Abstract][Full Text] [Related]
2. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial. Follath F Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Follath F; Cleland JG; Just H; Papp JG; Scholz H; Peuhkurinen K; Harjola VP; Mitrovic V; Abdalla M; Sandell EP; Lehtonen L; Lancet; 2002 Jul; 360(9328):196-202. PubMed ID: 12133653 [TBL] [Abstract][Full Text] [Related]
4. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure. Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930 [TBL] [Abstract][Full Text] [Related]
5. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure. Earl GL; Fitzpatrick JT Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899 [TBL] [Abstract][Full Text] [Related]
6. Considerations on the efficacy and safety of levosimendan in ischemic heart failure. Nieminen MS; Sandell EP Ital Heart J; 2003 May; 4 Suppl 2():39S-44S. PubMed ID: 14635369 [TBL] [Abstract][Full Text] [Related]
7. Levosimendan improves postresuscitation outcomes in a rat model of CPR. Huang L; Weil MH; Sun S; Cammarata G; Cao L; Tang W J Lab Clin Med; 2005 Nov; 146(5):256-61. PubMed ID: 16242524 [TBL] [Abstract][Full Text] [Related]
8. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use. Tasouli A; Papadopoulos K; Antoniou T; Kriaras I; Stavridis G; Degiannis D; Geroulanos S Eur J Cardiothorac Surg; 2007 Oct; 32(4):629-33. PubMed ID: 17702589 [TBL] [Abstract][Full Text] [Related]
10. [Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery]. Alvarez J; Bouzada M; Fernández AL; Caruezo V; Taboada M; Rodríguez J; Ginesta V; Rubio J; García-Bengoechea JB; González-Juanatey JR Rev Esp Cardiol; 2006 Apr; 59(4):338-45. PubMed ID: 16709386 [TBL] [Abstract][Full Text] [Related]
11. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series. Malliotakis P; Xenikakis T; Linardakis M; Hassoulas J Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345 [TBL] [Abstract][Full Text] [Related]
12. Randomized clinical trials with levosimendan. Mebazaa A; Barraud D; Welschbillig S Am J Cardiol; 2005 Sep; 96(6A):74G-9G. PubMed ID: 16181826 [TBL] [Abstract][Full Text] [Related]
13. Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study. Leppikangas H; Ruokonen E; Rutanen J; Kiviniemi V; Lindgren L; Kurola J Ann Emerg Med; 2009 Dec; 54(6):811-817.e1-3. PubMed ID: 19766354 [TBL] [Abstract][Full Text] [Related]
14. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079 [TBL] [Abstract][Full Text] [Related]
15. Weaning difficult-to-wean chronic obstructive pulmonary disease patients: a pilot study comparing initial hemodynamic effects of levosimendan and dobutamine. Ouanes-Besbes L; Ouanes I; Dachraoui F; Dimassi S; Mebazaa A; Abroug F J Crit Care; 2011 Feb; 26(1):15-21. PubMed ID: 20381295 [TBL] [Abstract][Full Text] [Related]
16. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. Mebazaa A; Nieminen MS; Packer M; Cohen-Solal A; Kleber FX; Pocock SJ; Thakkar R; Padley RJ; Põder P; Kivikko M; JAMA; 2007 May; 297(17):1883-91. PubMed ID: 17473298 [TBL] [Abstract][Full Text] [Related]
17. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair. Ponschab M; Hochmair N; Ghazwinian N; Mueller T; Plöchl W Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408 [TBL] [Abstract][Full Text] [Related]
18. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure. Cleland JG; Nikitin N; McGowan J Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409 [TBL] [Abstract][Full Text] [Related]
19. Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording. Despas F; Trouillet C; Franchitto N; Labrunee M; Galinier M; Senard JM; Pathak A Acute Card Care; 2010 Mar; 12(1):25-30. PubMed ID: 19929264 [TBL] [Abstract][Full Text] [Related]
20. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Kerbaul F; Rondelet B; Demester JP; Fesler P; Huez S; Naeije R; Brimioulle S Crit Care Med; 2006 Nov; 34(11):2814-9. PubMed ID: 16971854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]